genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Eukaryotic cell

Distinctions without a Difference: The Puzzling Argument about PASSIGE vs PASTE
Genome Editing

Distinctions without a Difference: The Puzzling Argument about PASSIGE vs PASTE

SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR
Drug Discovery

SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR

Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
Drug Discovery

Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence

Microtubules Start with Molecular Ring’s Closure, Keeping Target Hunt Open
Artificial Intelligence

Microtubules Start with Molecular Ring’s Closure, Keeping Target Hunt Open

Fanzor: First CRISPR-Like System Found in Eukaryotes
Genome Editing

Fanzor: First CRISPR-Like System Found in Eukaryotes

Harnessing Ubiquitylation for Drug Discovery
Biotech Briefs

Harnessing Ubiquitylation for Drug Discovery

Synthetic Genetic Circuits Precisely Modify Plant Root Growth
Genome Editing

Synthetic Genetic Circuits Precisely Modify Plant Root Growth

Using LAMPS to Improve Bioprocessing
Bioprocessing

Using LAMPS to Improve Bioprocessing

PTAB Sides with Broad Institute over CVC on CRISPR Patent Priority
Genome Editing

PTAB Sides with Broad Institute over CVC on CRISPR Patent Priority

New Ways in Which Cancer Cells Escape Damage Revealed
Cancer

New Ways in Which Cancer Cells Escape Damage Revealed

123...11Page 1 of 11

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up